Cargando…

Geo-referenced simulation of pharmaceuticals in whole watersheds: application of GREAT-ER 4.1 in Germany

The geo-referenced regional exposure assessment tool for European rivers (GREAT-ER) is designed to support river basin management or the implementation process within the EU Water Framework Directive by predicting spatially resolved exposure concentrations in whole watersheds. The usefulness of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lämmchen, Volker, Niebaum, Gunnar, Berlekamp, Jürgen, Klasmeier, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106600/
https://www.ncbi.nlm.nih.gov/pubmed/33411301
http://dx.doi.org/10.1007/s11356-020-12189-7
Descripción
Sumario:The geo-referenced regional exposure assessment tool for European rivers (GREAT-ER) is designed to support river basin management or the implementation process within the EU Water Framework Directive by predicting spatially resolved exposure concentrations in whole watersheds. The usefulness of the complimentary application of targeted monitoring and GREAT-ER simulations is demonstrated with case studies for three pharmaceuticals in selected German watersheds. Comparison with monitoring data corroborates the capability of the probabilistic model approach to predict the expected range of spatial surface water concentrations. Explicit consideration of local pharmaceutical emissions from hospitals or private doctor’s offices (e.g., for X-ray contrast agents) can improve predictions on the local scale without compromising regional exposure assessment. Pharmaceuticals exhibiting low concentrations hardly detectable with established analytical methods (e.g., EE2) can be evaluated with model simulations. Management scenarios allow for a priori assessment of risk reduction measures. In combination with targeted monitoring approaches, the GREAT-ER model can serve as valuable support tool for exposure and risk assessment of pharmaceuticals in whole watersheds. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11356-020-12189-7.